Skip to main content
Top
Published in: Abdominal Radiology 3/2004

01-05-2004 | Original article

PET-CT detection of abdominal recurrence of ovarian cancer: radiologic–surgical correlation

Authors: H. K. Pannu, C. Cohade, R. E. Bristow, E. K. Fishman, R. L. Wahl

Published in: Abdominal Radiology | Issue 3/2004

Login to get access

Abstract

The diagnosis of recurrent ovarian cancer can be difficult on cross-sectional imaging, and variable sensitivities and specificities have been reported for positron emission tomography (PET). Combined functional and anatomic imaging with PET plus computed tomography (CT) potentially allows for improved detection of tumor masses. We investigated the sensitivity, specificity, and accuracy of PET-CT for the diagnosis of recurrent ovarian cancer. Sixteen women with previously treated ovarian cancer underwent imaging on a combined PET-CT scanner followed by surgery to assess for possible recurrent disease. The fused PET-CT images were retrospectively reviewed for recurrent disease, and the results of PET-CT were compared with the operative notes. Eleven of the 16 patients had recurrent disease at surgery. The sensitivity, specificity, and accuracy of PET-CT for disease detection on a per-patient basis were 72.7%, 40%, and 62.5%, respectively. For cases of malignant adenopathy (n = 7), 100% were detected on PET-CT. For peritoneal lesions no larger than 1 cm (n = 23), 13% were detected on PET-CT. For peritoneal lesions larger than 1 cm (n = 8), 50% were detected on PET-CT. The sensitivity of PET-CT for recurrent ovarian cancer is moderate in patients with low volume disease. A trial involving a larger number of patients with a spectrum of disease volumes is necessary to determine the impact of PET-CT in clinical practice.
Literature
1.
go back to reference Buy, JN, Moss, AA, Ghossain, MA, et al. 1988Peritoneal implants from ovarian tumors: CT findingsRadiology169691694PubMed Buy, JN, Moss, AA, Ghossain, MA,  et al. 1988Peritoneal implants from ovarian tumors: CT findingsRadiology169691694PubMed
2.
go back to reference Coakley, FV, Choi, PH, Gougoutas, CA, et al. 2002Peritoneal metastases: detection with spiral CT in patients with ovarian cancerRadiology223495499PubMed Coakley, FV, Choi, PH, Gougoutas, CA,  et al. 2002Peritoneal metastases: detection with spiral CT in patients with ovarian cancerRadiology223495499PubMed
3.
go back to reference Prayer, L, Kainz, C, Kramer, J, et al. 1993CT and MR accuracy in the detection of tumor recurrence in patients treated for ovarian cancerJ Comput Assist Tomogr17626632PubMed Prayer, L, Kainz, C, Kramer, J,  et al. 1993CT and MR accuracy in the detection of tumor recurrence in patients treated for ovarian cancerJ Comput Assist Tomogr17626632PubMed
4.
go back to reference Low, RN, Saleh, F, Song, SYT, et al. 1999Treated ovarian cancer: comparison of MR imaging with serum CA-125 level and physical examination—a longitudinal studyRadiology211519528PubMed Low, RN, Saleh, F, Song, SYT,  et al. 1999Treated ovarian cancer: comparison of MR imaging with serum CA-125 level and physical examination—a longitudinal studyRadiology211519528PubMed
5.
go back to reference Low, RN, Semelka, RC, Worawattanakul, S, et al. 1999Extrahepatic abdominal imaging in patients with malignancy: comparison of MR imaging and helical CT, with subsequent surgical correlationRadiology210625632PubMed Low, RN, Semelka, RC, Worawattanakul, S,  et al. 1999Extrahepatic abdominal imaging in patients with malignancy: comparison of MR imaging and helical CT, with subsequent surgical correlationRadiology210625632PubMed
6.
go back to reference Bristow, RE, Simpkins, F, Pannu, HK, et al. 2002Positron emission tomography for detecting clinically occult surgically resectable metastatic ovarian cancerGynecol Oncol85196200CrossRefPubMed Bristow, RE, Simpkins, F, Pannu, HK,  et al. 2002Positron emission tomography for detecting clinically occult surgically resectable metastatic ovarian cancerGynecol Oncol85196200CrossRefPubMed
7.
go back to reference Torizuka, T, Nobezawa, S, Kanno, T, et al. 2002Ovarian cancer recurrence: role of whole-body positron emission tomography using 2-[fluorine-18]-fluoro-2-deoxy-d-glucoseEur J Nucl Med Mol Imaging29797803CrossRefPubMed Torizuka, T, Nobezawa, S, Kanno, T,  et al. 2002Ovarian cancer recurrence: role of whole-body positron emission tomography using 2-[fluorine-18]-fluoro-2-deoxy-d-glucoseEur J Nucl Med Mol Imaging29797803CrossRefPubMed
8.
go back to reference Nakamoto, Y, Saga, T, Ishimori, T, et al. 2001Clinical value of positron emission tomography with FDG for recurrent ovarian cancerAJR17614491454PubMed Nakamoto, Y, Saga, T, Ishimori, T,  et al. 2001Clinical value of positron emission tomography with FDG for recurrent ovarian cancerAJR17614491454PubMed
9.
go back to reference Rose, PG, Faulhaber, P, Miraldi, F, Abdul-Karim, FW 2001Positive emission tomography for evaluating a complete clinical response in patients with ovarian or peritoneal carcinoma: correlation with second-look laparotomyGynecol Oncol821721CrossRefPubMed Rose, PG, Faulhaber, P, Miraldi, F, Abdul-Karim, FW 2001Positive emission tomography for evaluating a complete clinical response in patients with ovarian or peritoneal carcinoma: correlation with second-look laparotomyGynecol Oncol821721CrossRefPubMed
10.
go back to reference Kubik-Huch, RA, Dorffler, W, von Schulthess, GK, et al. 2000Value of (18F)-FDG positron emission tomography, computed tomography, and magnetic resonance imaging in diagnosing primary and recurrent ovarian carcinoma.Eur Radiol10761767CrossRefPubMed Kubik-Huch, RA, Dorffler, W, von Schulthess, GK,  et al. 2000Value of (18F)-FDG positron emission tomography, computed tomography, and magnetic resonance imaging in diagnosing primary and recurrent ovarian carcinoma.Eur Radiol10761767CrossRefPubMed
11.
go back to reference Cho, SM, Ha, HK, Byun, JY, et al. 2002Usefulness of FDG PET for assessment of early recurrent epithelial ovarian cancerAJR179391395PubMed Cho, SM, Ha, HK, Byun, JY,  et al. 2002Usefulness of FDG PET for assessment of early recurrent epithelial ovarian cancerAJR179391395PubMed
12.
go back to reference Yen, RF, Sun, SS, Shen, YY, et al. 2001Whole body positron emission tomography with 18F-fluoro-2-deoxyglucose for the detection of recurrent ovarian cancerAnticancer Res2136913694PubMed Yen, RF, Sun, SS, Shen, YY,  et al. 2001Whole body positron emission tomography with 18F-fluoro-2-deoxyglucose for the detection of recurrent ovarian cancerAnticancer Res2136913694PubMed
13.
go back to reference Zimny, M, Siggelkow, W, Schroder, W, et al. 20012-[Fluorine-18]-fluoro-2-deoxy-d-glucose positron emission tomography in the diagnosis of recurrent ovarian cancerGynecol Oncol83310315CrossRefPubMed Zimny, M, Siggelkow, W, Schroder, W,  et al. 20012-[Fluorine-18]-fluoro-2-deoxy-d-glucose positron emission tomography in the diagnosis of recurrent ovarian cancerGynecol Oncol83310315CrossRefPubMed
14.
go back to reference Karlan, BY, Hawkins, R, Hoh, C, et al. 1993Whole-body positron emission tomography with 2-[18F]-fluoro-2-deoxy-d-glucose can detect recurrent ovarian carcinomaGynecol Oncol51175181CrossRefPubMed Karlan, BY, Hawkins, R, Hoh, C,  et al. 1993Whole-body positron emission tomography with 2-[18F]-fluoro-2-deoxy-d-glucose can detect recurrent ovarian carcinomaGynecol Oncol51175181CrossRefPubMed
15.
go back to reference Makhija, S, Howden, N, Edwards, R, et al. 2002Positron emission tomography/computed tomography imaging for the detection of recurrent ovarian and fallopian tube carcinoma: a retrospective reviewGynecol Oncol855358CrossRefPubMed Makhija, S, Howden, N, Edwards, R,  et al. 2002Positron emission tomography/computed tomography imaging for the detection of recurrent ovarian and fallopian tube carcinoma: a retrospective reviewGynecol Oncol855358CrossRefPubMed
16.
go back to reference Coakley, FV, Choi, PH, Gougoutas, CA, et al. 2002Peritoneal metastases: detection with spiral CT in patients with ovarian cancerRadiology223495499PubMed Coakley, FV, Choi, PH, Gougoutas, CA,  et al. 2002Peritoneal metastases: detection with spiral CT in patients with ovarian cancerRadiology223495499PubMed
17.
go back to reference Antoch, G, Freudenberg, LS, Stattaus, J, et al. 2002Whole-body positron emission tomography-CT: optimized CT using oral and IV contrast materialsAJR17915551560PubMed Antoch, G, Freudenberg, LS, Stattaus, J,  et al. 2002Whole-body positron emission tomography-CT: optimized CT using oral and IV contrast materialsAJR17915551560PubMed
18.
go back to reference Dizendorf, EV, Treyer, V, Von Schulthess, GK, Hany, TF 2002Application of oral contrast media in coregistered positron emission tomography–CT.AJR179477481PubMed Dizendorf, EV, Treyer, V, Von Schulthess, GK, Hany, TF 2002Application of oral contrast media in coregistered positron emission tomography–CT.AJR179477481PubMed
19.
go back to reference Pannu, HK, Bristow, RE, Cohade, C, Fishman, EK, Wahl, RL 2004PET–CT in recurrent ovarian cancer.Radiographics... Pannu, HK, Bristow, RE, Cohade, C, Fishman, EK, Wahl, RL 2004PET–CT in recurrent ovarian cancer.Radiographics...
Metadata
Title
PET-CT detection of abdominal recurrence of ovarian cancer: radiologic–surgical correlation
Authors
H. K. Pannu
C. Cohade
R. E. Bristow
E. K. Fishman
R. L. Wahl
Publication date
01-05-2004
Publisher
Springer-Verlag
Published in
Abdominal Radiology / Issue 3/2004
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-003-0118-7

Other articles of this Issue 3/2004

Abdominal Radiology 3/2004 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.